<![CDATA[Optimizing Cilta-Cel Sequencing and Community Coordination in Multiple Myeloma]]>

ConferenceCilta-CelNeutral

AI Analysis

Summary

Hematologic specialists discussed the positioning of ciltacabtagene autoleucel (Cilta-Cel) in the treatment paradigm for multiple myeloma at first relapse and beyond. The discussion focused on optimizing sequencing and community coordination strategies.

Importance:2/10

Sentiment:

0.00

multiple myelomaCAR-T cell therapycilta-celtreatment sequencinghematology

Related Companies

$CHCT

Read the original article

Published by Cancer Network on September 23, 2026 5:00 PM

Read Original